ESC 365 - Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?

Open Access

Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?

Session: Lipid-lowering therapy beyond LDL Cholesterol

Topic: Lipids

Speaker: Professor J. Chapman (Paris, FR)

Event: ESC Congress 2018

Congress Session

About the speaker

Professor John Chapman

Sorbonne University, Paris (France)

15 presentations

0 follower

3 more presentations in this session

Lp(a): Is there any benefit from reducing it?

Speaker: Professor B. Ference (Cambridge, GB)

Is it time to sing the requiem for HDL cholesterol?

Speaker: Professor U. Laufs (Leipzig, DE)

Does LDL induce inflammation? If so, does it matter?

Speaker: Professor J. Jukema (Leiden, NL)

Access the full session

Lipid-lowering therapy beyond LDL Cholesterol

Speakers: Professor J. Chapman, Professor B. Ference, Professor U. Laufs, Professor J. Jukema

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

Related content

Open Access

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - panel .

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

Triglycerides: the underestimated player.

27 August 2021

This platform is supported by